Viveve Medical Inc  

(Public, OTCMKTS:VIVMF)   Watch this stock  
+0.010 (2.78%)
Dec 26 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.37 - 0.50
52 week 0.35 - 5.40
Open 0.37
Vol / Avg. 967.00/6,570.00
Mkt cap 6.67M
P/E 0.70
Div/yield     -
EPS 0.53
Shares 18.02M
Beta 0.42
Inst. own 0%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -14576.02% 274.65%
Operating margin -13735.10% -626.22%
EBITD margin - -365.07%
Return on average assets -519.03% 313.99%
Return on average equity - -
Employees 6 -
CDP Score - -


150 Commercial St
SUNNYVALE, CA 94086-5201
United States - Map
+1-408-5301900 (Phone)
+1-408-5301919 (Fax)

Website links


Viveve Medical, Inc., formerly PLC Systems Inc. (PLC), is a medical device company specializing in technologies for the cardiac and vascular markets. The Company markets its product, RenalGuard, outside the United States. The RenalGuard System consists of a console and accompanying single-use sets. RenalGuard is designed to reduce the toxic effects that contrast media can have on the kidneys. The Company's RenalGuard System is a automated measurement and matched fluid replacement device. The system consists of a fluid balancing system and a console with a delivery mechanism for sterile replacement fluid, including detectors, monitors and alarms.

Officers and directors

Patricia K. Scheller Chief Executive Officer, Director
Age: 53
Scott C. Durbin Chief Financial Officer
Alan Curtis Vice President - Regulatory, Clinical and Quality
Steve Lopez Director - Operations
Mark Samuel Colella Independent Director
Age: 41
Daniel S. Janney Independent Director
Age: 48
Carl J. Simpson Independent Director
Brigitte H. Smith Independent Director
Age: 46